BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2906371)

  • 1. Nifedipine substituted for minoxidil in the treatment of refractory hypertension.
    Heagerty AM; Bing RF; Thurston H; Swales JD
    J Hum Hypertens; 1987 Sep; 1(2):83-6. PubMed ID: 2906371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of refractory hypertension with combined minoxidil and captopril in low doses].
    Palatini P; Pessina AC; Sperti G; Fortunato V; Gava R; Dal Palù C
    G Ital Cardiol; 1984 Jun; 14(6):401-6. PubMed ID: 6148288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of severe hypertension with minoxidil.
    Nawar T; Nolin L; Plante GE; Caron C; Montambault P
    Can Med Assoc J; 1977 Nov; 117(10):1178-82. PubMed ID: 603847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of minoxidil therapy in refractory hypertension. A prospective trial in patients with various degrees of renal insufficiency.
    Andreucci VE; Usberti M; Federico S; Pecoraro C; Balletta M; Meccariello S
    Clin Nephrol; 1983 Feb; 19(2):55-60. PubMed ID: 6340875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minoxidil, nadolol, and a diuretic. Once-a-day therapy for resistant hypertension.
    Spitalewitz S; Porush JG; Reiser IW
    Arch Intern Med; 1986 May; 146(5):882-6. PubMed ID: 3963979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined minoxidil, beta-blocking agents and diuretics in the treatment of accelerated hypertension].
    Palatini P; Pessina AC; Semplicini A; Veronese P; Ventura E; Rizzetto S; Dal Palù C
    Boll Soc Ital Cardiol; 1978; 23(9):1445-51. PubMed ID: 45248
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combination of beta-blocking agents, diuretics and pressidil (minoxidil) in severe arterial hypertension resisting other therapy].
    Angelino PF; Lavezzaro GC; Castaldo D
    Boll Soc Ital Cardiol; 1978; 23(9):1453-62. PubMed ID: 45249
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined treatment with minoxidil and captopril in refractory hypertension.
    Traub YM; Levey BA
    Arch Intern Med; 1983 Jun; 143(6):1142-4. PubMed ID: 6344825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minoxidil in the management of intractable hypertension.
    Mackay A; Isles C; Henderson I; Fife R; Kennedy AC
    Q J Med; 1981; 50(198):175-90. PubMed ID: 7302117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrendipine in hypertension that is difficult to control.
    Höffler D; Stoepel K
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1060-2. PubMed ID: 6085367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term minoxidil treatment in refractory hypertension and renal failure.
    Pontremoli R; Robaudo C; Gaiter A; Massarino F; Deferrari G
    Clin Nephrol; 1991 Jan; 35(1):39-43. PubMed ID: 2007295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-a-day triple therapy with low-dose minoxidil for moderate hypertension.
    Traub YM; Boner G; Johnsen AM; McDonald RH; Shapiro AP; Rosenfeld JB
    Isr J Med Sci; 1986 May; 22(5):360-4. PubMed ID: 3744783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minoxidil in combination with a beta-adrenergic blocker and a diuretic as an antihypertensive in patients refractory to available medications.
    Seedat YK; Rawat R
    S Afr Med J; 1981 May; 59(20):707-9. PubMed ID: 6111848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised crossover comparison of reserpine and sustained-release nifedipine in hypertension.
    Manyemba J
    Cent Afr J Med; 1997 Dec; 43(12):344-9. PubMed ID: 9631111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
    Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
    J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of nifedipine as an adjunct to current antihypertensive therapy.
    Evans MG; Olanoff LS; Hurwitz G; Cowart TD; Conradi EC
    Arch Intern Med; 1984 May; 144(5):985-7. PubMed ID: 6143543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.